DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING ASSAY RP-HPLC METHOD FOR THE ESTIMATION OF ANIDULAFUNGIN AND RELATED COMPOUNDS IN PARENTERAL DOSAGE FORM

C. S. Tejasvini, S. Sekhar, R. Verma*, L. Kumar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

RP HPLC method has been developed for the detection of Anidulafungin and to separate its related compounds. Anidulafungin was separated on a Zodiac C18 (150 × 4.6mm × 3.0µm) analytical column. The solvent system used for assay was Trifluoroacetic acid buffer: Acetonitrile (52:48 %v/v) of pH 4.7 at 1.5 ml/min flow rate and the detection at 300nm wavelength. The solvent system used for related compounds separation was phosphate buffer as Mobile phase A and Acetonitrile as Mobile phase B at 0.8 ml/min flow and the detection at 220nm wavelength and injection volume of 50 µL whose elution is gradient. The method has been validated according to the ICH guidelines for linearity, accuracy, the limit of detection, the limit of quantification, solution stability and robustness. The linear regression coefficient was found to be 1.000 with a slope of 28225.77 and an intercept is 35762.79. The accuracy was determined by a three different level recovery study and the mean % recovery was 101.0-101.5 which is within the specified limits. LOD and LOQ values were found to be 0.083 and 0.250ppm, respectively. The method developed was robust, simple and accurate. It is therefore appropriate for routine analysis.

Original languageEnglish
Pages (from-to)280-287
Number of pages8
JournalRasayan Journal of Chemistry
Volume15
Issue number1
DOIs
Publication statusPublished - 01-01-2022

All Science Journal Classification (ASJC) codes

  • General Chemistry
  • Biochemistry
  • General Chemical Engineering
  • General Energy
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING ASSAY RP-HPLC METHOD FOR THE ESTIMATION OF ANIDULAFUNGIN AND RELATED COMPOUNDS IN PARENTERAL DOSAGE FORM'. Together they form a unique fingerprint.

Cite this